ZGN heads into its May 4 first-quarter results as one of the most decisively bullish options setups in the luxury space right now.
The options market is the clearest signal. Call demand has swamped puts so aggressively that the put/call ratio has collapsed to 0.38 — nearly two standard deviations below its 20-day average of 0.80. That is the most one-sided bullish reading in the recent history of the name, sitting near the 52-week floor and a complete reversal from the defensive stance that prevailed through much of April, when the PCR ran above 1.0. The stock has validated that optimism: ZGN has added 19% in the past month, closing at $12.44, with another 2.6% added on Friday alone.
Short interest tells a different, quieter story. Bears hold just 1.4% of the free float, a position that has ticked up roughly 9% over the past week but remains too modest to constitute a meaningful headwind. Borrowing costs are negligible at 0.9%, and borrow availability is ample, meaning no squeeze dynamics are in play. The ORTEX short score has edged higher to 60.4 over the past two weeks — consistent with a slow rebuild in bearish positioning — but this is far from an extreme reading. The lending market is not charged.
The analyst debate reflects the stock's dramatic recovery from its lows. TD Cowen raised its target to $13 on May 1 while keeping a Hold — a tacit acknowledgment of the momentum without conviction. The broader Street consensus sits at a mean target of $10.80, which is actually below the current price, implying the analyst community as a whole has been caught behind the move. JP Morgan initiated at Overweight last September with an $11 target. Morgan Stanley carries an Underweight. The bull case rests on Zegna's direct-to-consumer premiumisation push and the Thom Browne brand's recovery potential; the bear case centres on luxury demand fragility in a macro slowdown and the stock's valuation re-rating — the P/E has expanded to 23x trailing earnings on an EPS of just $0.48, and EV/EBITDA now runs near 7.6x on estimated revenues of roughly $2.35 billion. EPS momentum over the past 30 days is in the 95th percentile, a standout score, though that strength is markedly weaker on a 90-day view (59th percentile), suggesting the revision tide is still finding its level.
Ownership is tightly held. The founding Zegna family vehicle Monterubello controls 57% of shares, and Temasek holds another 10%. Barrow Hanley added 1.8 million shares as of January. That concentrated structure limits float and amplifies any price move on the print. The most recent comparable quarterly event, in March, produced an 8.2% single-day gain — the print will test whether the current options optimism and 19% monthly run-up are supported by a revenue picture that justifies the market's decision to run ahead of analyst targets.
See the live data behind this article on ORTEX.
Open ZGN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
